Every RabMAb primary antibody is tested in western blot, IHC, ICC/IF, IP and flow cytometry and in multiple species (Human, Mouse, Rat) before release.
RabMAb products benefits from the diverse epitope recognition of the rabbit immune system. Combined with the high specificity of a monoclonal antibody, they deliver high quality results in multiple applications.
An average of 3 recommended applications per RabMAb product
For IHC, all RabMAb primary antibodies are tested on formalin-fixed and paraffin-embedded (FFPE) human tissue array for more accurate verification of antibody sensitivity and localization.